INNOVATION

Tal Zaks

Scientist

Among the companies announcing a vaccine for the coronavirus pandemic at the end of 2020 was US biotechnology pioneer Moderna, after the conducted trials discovered a success rate of more than 94 percent. Moderna’s chief medical officer, Dr. Tal Zaks, has expressed confidence that the vaccine will quickly make its way to Americans. “We are on track to deliver to the US government the first hundred million doses, and the US government has optioned to purchase more,” Zaks said in a radio interview. Zaks received his medical degree and doctorate from Ben Gurion University in Israel and served in the IDF Forces as a medic before pursuing his career in the US. (Photo: Moderna / Screenshot)